This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Opioid receptor
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
* The '''κ-opioid receptor''' binds opium-type ligands. For details see [[Student Project 3 for UMass Chemistry 423 Spring 2015]].<br /> | * The '''κ-opioid receptor''' binds opium-type ligands. For details see [[Student Project 3 for UMass Chemistry 423 Spring 2015]].<br /> | ||
* The '''δ-opioid receptor''' binds enkephalins. For details see [[Delta opioid receptor]]. | * The '''δ-opioid receptor''' binds enkephalins. For details see [[Delta opioid receptor]]. | ||
| + | * The '''Nociceptin/orphanin FQ opioid receptor''' binds the heptadecapeptide orphanin<ref>PMID:23395957</ref>. | ||
== Relevance == | == Relevance == | ||
Revision as of 08:32, 9 June 2016
| |||||||||||
3D structures of opioid receptor
Updated on 09-June-2016
References
- ↑ Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr Drug Targets. 2012 Feb;13(2):230-46. PMID:22204322
- ↑ Donica CL, Awwad HO, Thakker DR, Standifer KM. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb , 8. PMID:23395957 doi:http://dx.doi.org/10.1124/mol.112.084632
- ↑ Zaveri NT. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem. 2011;11(9):1151-6. PMID:21050175
- ↑ Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets. 2007 Jan;8(1):117-35. PMID:17266536
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Karsten Theis, Joel L. Sussman
